
Copyright © All Samadhan - Operated by M/S. Genius Experts | All Rights Reserved
DBID
Registration ID: 176322642
Trade License: TRAD/DNCC/040904/2023

Opsonin Pharma Ltd. · Tablet
/ Piece
The information provided on All Samadhan is intended for general informational purposes only and is prepared based on our best practices. It is not a substitute for professional medical advice, diagnosis, or treatment. While we strive to keep the information accurate and up to date, we do not guarantee its completeness or accuracy. The absence of specific information or warnings about any medicine or service should not be considered as an assurance or endorsement by All Samadhan. All Samadhan shall not be held responsible for any consequences arising from the use of this information. We strongly recommend consulting a qualified healthcare professional or physician for any medical concerns, questions, or clarifications.
This combination tablet is indicated for use in improving the nutritional status of women throughout the pregnancy. This is a micronutrient supplements but not a substitute of balanced diet during pregnancy.
Multiple Micronutrient Supplements (MMS) is a nutritional supplement for use during pregnancy based on United Nations International Multiple Micronutrient Antenatal Preparation (UNIMMAP) formulation following WFIO specification. It contains 15 micronutrients including Iron and Folic Acid (IFA) at dosages that approximate the recommended dietary allowances for pregnancy. Micronutrients are only needed in very small quantities but are essential for normal physiological function, growth and development. Deficiencies of micronutrients such as vitamin A, iron, iodine and folate are particularly very common during pregnancy due to increased nutrient requirements of the mother and developing fetus. These deficiencies can negatively impact the health of the mother, her pregnancy, as well as the health of the newborn baby. Recent evidence shows that the provision of MMS for women starting early in pregnancy provides clear benefits for both women and their unborn and newborn infants, beyond IFA supplementation alone. MMS can improve birth outcomes significantly by reducing the risk of low birth weight (LBW), being born small-for-gestational age (SGA), and preterm births.
Take only one tablet daily starting as soon as possible after conception and continue to use 180 tablets for 6 months throughout the pregnancy or as directed by the physician. It is not recommended for children and adolescents.
No drug interactions have been reported.
Daily intake of recommended dose has no risk of adverse health effects in almost all individuals.
This is recommended to use only during pregnancy.
Accidental overdose of iron containing products is a leading cause of fatal poisoning in children under 6 years. In case of accidental overdose, call a doctor or immediately visit the nearest hospital.
Keep out of the reach of children. Keep between 15°C to 30°C, protect from light and humidity.